Daily Newsletter

14 September 2023

Daily Newsletter

14 September 2023

iGan Partners collaborates with Mexican healthcare entities

St Andrews Medical Center will test advanced medical devices and software at its facility.

September 14 2023

iGan Partners has entered a collaboration with two Mexico-based healthcare entities, St Andrews Medical Center and Previta.

The partnership aims to close the gap in quality healthcare and bring access to healthcare technologies in Mexico, Canada, and the US.

Together they will implement value-based healthcare and clinical evidence-based medical technology to further save lives and reduce costs.

iGan Partners chief medical officer Dr Lorena Torá said: “Through our expertise and resources, we aim to transform the healthcare landscape in Mexico and act as a gateway to ensuring that patients have access to the best medical technologies available.

“This collaboration represents our commitment to improving lives and making a positive impact on the healthcare industry.”

Under the collaboration, St Andrews Medical Center will test advanced medical devices and software at its facility for expediting studies and innovative healthcare deployments.

Previta will provide quality healthcare services to the homes of patients and hospitals through remote monitoring.

Previta CEO Dr Morgan Guerra said: “At Previta, we are enthusiastic about this collaboration and the potential it holds for patients and healthcare providers.

“By leveraging our expertise in preventive and treatment services, combined with innovative technologies, we can enhance patient outcomes and make a significant positive impact on the delivery of healthcare services throughout Mexico and beyond.”

Is it time for the healthcare sector to fully embrace the benefits of digitalization and AI?

Primarily due to COVID-19, the healthcare sector has witnessed an acceleration in digital transformation, which has improved efficiencies and enhanced patient outcomes. AI can revolutionize the drug discovery process and significantly reduce the time and cost to get a drug to market, particularly in areas of unmet need. There is also huge potential for AI in medical diagnostics. However, using healthcare data for AI development raises data privacy concerns, thereby limiting its adoption.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close